SEC Form 4 · accession 0001437749-16-036188
Stablecoin Development Corp · SDEV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pioneer Pharma (Singapore) Pte. Ltd.
10% Owner
Period of report
Aug 1, 2016
Accepted (ET)
Aug 2, 2016 · 1:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001389545
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2016 | A | 1,308,901 | $1.91 | A | 3,698,219 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF2 | $1.91 | Aug 1, 2016 | A | 654,451 | A | Aug 2, 2016 | Aug 2, 2026 | Common Stock | 654,451 | 1,490,202 | D |
Explanation of responses
- F1Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate 2,094,241 shares on July 31, 2016.
- F2Warrant acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate 1,047,121 warrants on July 31, 2016.